Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AZN

Astrazeneca (AZN)

Astrazeneca Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:AZN
DateTimeSourceHeadlineSymbolCompany
02/06/20254:37AMAlliance NewsAlliance NewsEXTRA: Astra shows weight loss drugs "aren't only game in town"LSE:AZNAstrazeneca Plc
02/06/20254:37AMAlliance NewsAlliance NewsEXTRA: Astra shows weight loss drugs "aren't only game in town"LSE:AZNAstrazeneca Plc
02/06/20253:42AMAlliance NewsAlliance NewsCancer drugs help drive fourth-quarter sales beat at AstraZenecaLSE:AZNAstrazeneca Plc
02/06/20253:42AMAlliance NewsAlliance NewsCancer drugs help drive fourth-quarter sales beat at AstraZenecaLSE:AZNAstrazeneca Plc
02/06/20252:00AMRNS Regulatory NewsAstraZeneca PLC Final ResultsLSE:AZNAstrazeneca Plc
02/03/202512:00PMRNS Regulatory NewsAstraZeneca PLC Total Voting RightsLSE:AZNAstrazeneca Plc
02/03/20257:16AMAlliance NewsAlliance NewsEARNINGS PREVIEW: AstraZeneca set for "industry-leading" 2024 growthLSE:AZNAstrazeneca Plc
02/03/20257:16AMAlliance NewsAlliance NewsEARNINGS PREVIEW: AstraZeneca set for "industry-leading" 2024 growthLSE:AZNAstrazeneca Plc
02/03/20253:34AMAlliance NewsAlliance NewsAstraZeneca's Imfinzi endorsed for EU approval for lung cancer careLSE:AZNAstrazeneca Plc
02/03/20253:34AMAlliance NewsAlliance NewsAstraZeneca's Imfinzi endorsed for EU approval for lung cancer careLSE:AZNAstrazeneca Plc
02/03/20252:00AMRNS Regulatory NewsAstraZeneca PLC Imfinzi recommended for EU approval for LS-SCLCLSE:AZNAstrazeneca Plc
01/31/20251:20PMAlliance NewsAlliance NewsAstraZeneca pulls UK investment after dispute over Government supportLSE:AZNAstrazeneca Plc
01/31/20251:20PMAlliance NewsAlliance NewsAstraZeneca pulls UK investment after dispute over Government supportLSE:AZNAstrazeneca Plc
01/28/20252:00AMRNS Regulatory NewsAstraZeneca PLC Enhertu approved in US for breast cancer post ETLSE:AZNAstrazeneca Plc
01/28/20252:00AMAlliance NewsAlliance NewsAstraZeneca's and Daiichi Sankyo's Enhertu wins new approval in USLSE:AZNAstrazeneca Plc
01/28/20252:00AMAlliance NewsAlliance NewsAstraZeneca's and Daiichi Sankyo's Enhertu wins new approval in USLSE:AZNAstrazeneca Plc
01/23/20253:34PMAlliance NewsAlliance NewsAstraZeneca makes USD570 million investment in Canada in pipeline pushLSE:AZNAstrazeneca Plc
01/23/20253:34PMAlliance NewsAlliance NewsAstraZeneca makes USD570 million investment in Canada in pipeline pushLSE:AZNAstrazeneca Plc
01/20/20253:38AMAlliance NewsAlliance NewsAstraZeneca and Daiichi's Datroway wins US FDA breast cancer approvalLSE:AZNAstrazeneca Plc
01/20/20253:38AMAlliance NewsAlliance NewsAstraZeneca and Daiichi's Datroway wins US FDA breast cancer approvalLSE:AZNAstrazeneca Plc
01/20/20252:00AMRNS Regulatory NewsAstraZeneca PLC Dato-DXd approved in US for HR+ breast cancerLSE:AZNAstrazeneca Plc
01/17/20253:16AMAlliance NewsAlliance NewsAstraZeneca's Calquence gets US approval for mantle cell lymphomaLSE:AZNAstrazeneca Plc
01/17/20253:16AMAlliance NewsAlliance NewsAstraZeneca's Calquence gets US approval for mantle cell lymphomaLSE:AZNAstrazeneca Plc
01/17/20252:00AMRNS Regulatory NewsAstraZeneca PLC Calquence combination approved in US for 1L MCLLSE:AZNAstrazeneca Plc
01/13/20254:19AMAlliance NewsAlliance NewsAstraZeneca and Daiichi Sankyo cheer priority US review of cancer drugLSE:AZNAstrazeneca Plc
01/13/20254:19AMAlliance NewsAlliance NewsAstraZeneca and Daiichi Sankyo cheer priority US review of cancer drugLSE:AZNAstrazeneca Plc
01/09/20256:25AMAlliance NewsAlliance NewsAstraZeneca breast cancer drug Lynparza given green light for NHS useLSE:AZNAstrazeneca Plc
01/09/20256:25AMAlliance NewsAlliance NewsAstraZeneca breast cancer drug Lynparza given green light for NHS useLSE:AZNAstrazeneca Plc
01/02/202510:00AMRNS Regulatory NewsAstraZeneca PLC Total Voting RightsLSE:AZNAstrazeneca Plc
12/24/20243:20AMAlliance NewsAlliance NewsAstraZeneca and Daiichi withdraw EU application for lung cancer drugLSE:AZNAstrazeneca Plc
 Showing the most relevant articles for your search:LSE:AZN